Disruptive fluorescent technologies for inflammatory bowel diseases

Project description

Novel diagnostic tools for inflammatory bowel diseases

Nearly three million people in Europe alone suffer from inflammatory bowel diseases (IBD), a group of conditions associated with inflammation in the gastrointestinal tract. Colonoscopy remains the gold standard method for the diagnosis and monitoring of these disorders. The EU-funded IBDIMAGE project aims to deliver a reagent toolbox that can measure in real time the activity of immune cells, which is an important indicator of IBD state. These reagents were developed during the ERC DYNAFLUORS project and constitute optimal imaging tools for a more accurate and personalised therapeutic approach for IBD patients. Moreover, they have the potential to lead to novel point-of-care diagnostics for IBD.

Fields of science

• medical and health sciences › basic medicine › pharmacology and pharmacy › drug discovery
• medical and health sciences › clinical medicine › gastroenterology › inflammatory bowel disease

Programme(s)

• H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC) Main Programme

Topic(s)

• ERC-2020-POC - Call for proposals for ERC Proof of Concept Grant

Call for proposal

ERC-2020-PoC

See other projects for this call

Funding Scheme

ERC-POC-LS - ERC Proof of Concept Lump Sum Pilot

Host institution

THE UNIVERSITY OF EDINBURGH

Net EU contribution

€ 150 000,00

Address

Old College, South Bridge
EH8 9YL Edinburgh
United Kingdom

Region

Eastern Scotland › Edinburgh

Activity type

Higher or Secondary Education Establishments

Links

Non-EU contribution

No data

Beneficiaries (1)

THE UNIVERSITY OF EDINBURGH

United Kingdom

Net EU contribution

€ 150 000,00

Address

Old College, South Bridge
EH8 9YL Edinburgh

Region

Eastern Scotland › Edinburgh

Activity type

Higher or Secondary Education Establishments

Links

Non-EU contribution

No data